Against a backdrop of persistent economic and geopolitical uncertainty, acquirers are refining their strategies in a market increasingly shaped by portfolio reviews. More disciplined than ever, they are prioritising scientific credibility and highly engaged independent brands with strong expansion potential, rather than pursuing growth at any cost.
